Two green and sensitive spectrofluorimetric approaches for determination of Ambroxol and guaifenesin in their single and combined pharmaceutical formulations

• Published in: Luminescence (Chichester, England) England), 2024-03, Vol.39 (3), p.e4711-n/a
• Main Authors: Elawadi, Ghidaa G., Elsebaei, Fawzi, Fathy, Mona E., Metwally, Mohammed E.‐S.
• Format: Article
• Language: English
• Subjects: Ambroxol; Analytical methods; Cost analysis; cough preparations; Drug Compounding; Drugs; erythrosine B; Excitation; Fluorescence; green chemistry; Guaifenesin - analysis; Mathematical analysis; native fluorescence; Pharmaceutical Preparations; Pharmaceuticals; Quality control; Raw materials; Spectrofluorimetry; Spectrometry, Fluorescence - methods; Wavelengths
• ISSN: 1522-7235; 1522-7243
• DOI: 10.1002/bio.4711

Ambroxol hydrochloride (AMX) and guaifenesin (GFN) are approved drugs utilized to treat coughs through their potent mucolytic and expectorant properties. Due to their massive, combined administration in many illnesses, there is a persistent need for their concurrent estimation in different pharmaceutical formulations. Two sensitive, environmentally friendly spectrofluorimetric methods were developed. AMX was determined using the first method (I) without interference from GFN. This method depends on the quenching of Erythrosine B (EB) native fluorescence at 552 nm after excitation at 527 nm due to the formation of a non‐fluorescent AMX‐EB ion‐pair complex in Britton–Robinson buffer (BRB) solution pH (3.5). The concentration plot is linear over the 0.25–5.0 μg/mL range, with a mean percent found value of 99.74%. Method (II) depends on measuring the native fluorescence of aqueous GFN solution at two analytical wavelengths, either 300 or 600 nm, after excitation at 274 nm. Relative fluorescence intensity (RFI)–concentration plots are linear over the ranges of 0.02–0.5 and 0.1–2.0 μg/ml, with mean percent found at 99.96% and 99.91% at dual wavelengths, respectively. The proposed methods were successfully applied to assay both drugs in raw materials and different single and combined pharmaceutical formulations. These methods have been thoroughly validated following International Committee on Harmonisation (ICH) guidelines. National Environmental Methods Index, Analytical Eco‐Scale, and Green Analytical Procedure Index were used to prove greenness, thereby enhancing their applicability. The proposed techniques provide straightforward, precise, and cost‐effective solutions for routine formulation analysis in quality control laboratories. Two fluorescence‐based techniques to determine Ambroxol (AMX) and Guaifenesin (GFN) in their isolated forms or combined in pharmaceutical formulations without interference from each other.